Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 228,988 shares at $11.66 ($2.7M) on 2021-03-01, disclosed to the SEC on 2021-03-03.
Open-market sale of $2.7M PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $11.66 | 29,702 | $346K | 13.0% |
| 2 | $11.66 | 29,702 | $346K | 13.0% |
| 3 | $11.66 | 27,226 | $317K | 11.9% |
| 4 | $11.66 | 27,226 | $317K | 11.9% |
| 5 | $12.12 | 484 | $6K | 0.2% |
| 6 | $12.12 | 528 |
| $6K |
| 0.2% |
| 7 | $11.54 | 27,290 | $315K | 11.9% |
| 8 | $11.54 | 27,290 | $315K | 11.9% |
| 9 | $11.54 | 29,770 | $344K | 12.9% |
| 10 | $11.54 | 29,770 | $344K | 12.9% |
| Total | $11.60 avg | 228,988 | $2.7M | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |